Metabolite profiling of antidepressant drug action reveals novel drug targets beyond monoamine elevation

por Webhofer, C, Gormanns, P, Tolstikov, V, Zieglgänsberger, W, Sillaber, I, Holsboer, F, Turck, C W
Publicado 2011

Delineation of molecular pathway activities of the chronic antidepressant treatment response suggests important roles for glutamatergic and ubiquitin–proteasome systems

por Park, D I, Dournes, C, Sillaber, I, Ising, M, Asara, J M, Webhofer, C, Filiou, M D, Müller, M B, Turck, C W
Publicado 2017